| °Ë»ö°á°ú: ÃÑ 64°³ Áß 1 - 20 |
À̹¶õÁ¤(¾ÆÀÚÆ¼¿ÀÇÁ¸°)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°
| Á¦Ç°¸í¡ã | ¼ººÐ¸í | ÁÖ¼ººÐÄÚµå | Ç¥ÁØÄÚµå | ÆÇ¸Å»ç | °í½Ã¹øÈ£ | Àû¿ëÀÏ |
| °¡¿Àºê¸¯Á¤80mg(ÆäºÏ¼Ò½ºÅ¸Æ®)_(80mg/1Á¤) | febuxostat | 567401ATB | 649103040 | Çѱ¹ÈÞÅØ½ºÁ¦¾à(ÁÖ) | 20150021 | 20150423 |
| ±¸ÁÖÅäÆÄ½ÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ¾Æ½ºÆÄ¸£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 669805920 | ±¸ÁÖÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
| ´ºÆÄƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ¾Æ½ºÆÄ¸£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 678601820 | (ÁÖ)´Ù»êÁ¦¾à | 20240466 | 20241011 |
| ´ëÇÑÅäÆÄ½ÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ¾Æ½ºÆÄ¸£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 645104830 | ´ëÇѾàǰ°ø¾÷(ÁÖ) | 20240466 | 20241011 |
| ¼¿ïÆäºÏ¼Ò½ºÅ¸Æ®Á¤40¹Ð¸®±×·¥_(40mg/1Á¤) | febuxostat | 567403ATB | 652904370 | (ÁÖ)¼¿ïÁ¦¾à | 20150021 | 20150423 |
| ¼¿ïÆäºÏ¼Ò½ºÅ¸Æ®Á¤80¹Ð¸®±×·¥_(80mg/1Á¤) | febuxostat | 567401ATB | 652904380 | (ÁÖ)¼¿ïÁ¦¾à | 20150021 | 20150423 |
| ¿ì¸®µéÅäÆÄ½ÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ¾Æ½ºÆÄ¸£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 670105110 | (ÁÖ)ÆÊÁ¨»çÀ̾𽺠| 20240466 | 20241011 |
| À¯¸®°¡Æ®Á¤40¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(40mg/1Á¤) | febuxostat | 567403ATB | 644502230 | (ÁÖ)À¯À¯Á¦¾à | 20150021 | 20150423 |
| À¯¸®°¡Æ®Á¤80¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(80mg/1Á¤) | febuxostat | 567401ATB | 644502220 | (ÁÖ)À¯À¯Á¦¾à | 20150021 | 20150423 |
| À¯¼Ò¸¯Á¤40¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(40mg/1Á¤) | febuxostat | 567403ATB | 645305220 | ÇѸ²Á¦¾à(ÁÖ) | 20150021 | 20150423 |
| À¯¼Ò¸¯Á¤80¹Ð¸®±×·¥(ÆäºÏ¼Ò½ºÅ¸Æ®)_(80mg/1Á¤) | febuxostat | 567401ATB | 645305210 | ÇѸ²Á¦¾à(ÁÖ) | 20150021 | 20150423 |
| ÀϼºÅäÆÄ½ÃƼ´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ¾Æ½ºÆÄ¸£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 655404160 | Àϼº½Å¾à(ÁÖ) | 20240466 | 20241011 |
| ÀèÆÄÁîÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ)_(5mg/1Á¤) | tofacitinib | 693701ATB | 645306420 | ÇѸ²Á¦¾à(ÁÖ) | 20240466 | 20241011 |
| Á¦´Ï§Á¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ¾Æ½ºÆÄ¸£Æ®»ê¿°)_(7.131mg/1Á¤) | tofacitinib aspartate (as tofacitinib) | 693601ATB | 649105160 | Çѱ¹ÈÞÅØ½ºÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
| Á¨½Ã´ÕÁ¤10¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ½ÃÆ®¸£»ê¿°)_(16.15mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627202ATB | 652607420 | ¾Ëº¸Á¨ÄÚ¸®¾Æ(ÁÖ) | 20240466 | 20241011 |
| Á¨½Ã´ÕÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ½ÃÆ®¸£»ê¿°)_(8.075mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627201ATB | 652607410 | ¾Ëº¸Á¨ÄÚ¸®¾Æ(ÁÖ) | 20240466 | 20241011 |
| Á©ÀÜÁî½Ã·´1mg/mL(ÅäÆÄ½ÃƼ´Õ½ÃÆ®¸£»ê¿°)_(240mL/º´) | tofacitinib citrate(as tofacitinib) | 627205ASY | 648903841 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
| Á©ÀÜÁîÁ¤10¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ½ÃÆ®¸£»ê¿°)_(16.155mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627202ATB | 648903410 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
| Á©ÀÜÁîÁ¤5¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ½ÃÆ®¸£»ê¿°)_(8.078mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627201ATB | 648902810 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |
| Á©ÀÜÁîXR¼¹æÁ¤11¹Ð¸®±×·¥(ÅäÆÄ½ÃƼ´Õ½ÃÆ®¸£»ê¿°)_(17.771mg/1Á¤) | tofacitinib citrate (as tofacitinib) | 627204ATR | 648903570 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240466 | 20241011 |